The U.S. House Oversight Committee is probing a collection of period tracking apps and data brokers in light of emerging concerns about how private health data might be weaponized in the dawning post-Roe v. Wade era.
The committee issued letters today to data brokers SafeGraph, Babel Street, Digital Envoy, Placer.ai and Gravy Analytics and app makers Flo Health, Glow, GP International, Clue developer BioWink and Digitalchemy Ventures.
In the letters, the representatives requested information on the companies’ data collection and retention policies “including documents and communica
コメント